SINOVA-M-14035 Serum Amyloid A (SAA) Quantitative Test Kit

Clinical Significance: Similar to CRP, SAA is used to evaluate the acute phase response process. SAA is a sensitive parameter that begins to rise approximately 8 hours after the onset of an inflammatory response and exceeds the upper reference limit earlier than CRP. However, the difference between the median value and the upper reference limit for CRP in healthy individuals is about tenfold, while it is only fivefold for SAA. In mild infections, such as many viral infections, an increase in SAA is more common than an increase in CRP. In infectious diseases, the absolute increase in SAA is higher than CRP, making SAA measurement particularly useful for differentiating between "normal" and minor acute phase responses. Approximately two-thirds of patients with the common cold show elevated SAA, while less than half show elevated CRP. In cases of viral infections, elevated levels of both SAA and CRP are observed in patients with adenovirus infections.
Product Specifications: 20 tests/box
Product Shelf Life: 18 months when sealed in an aluminum foil pouch. Use within 1 hour after opening the pouch.
Product Storage: Store the test card at 2℃-30℃.
 
Usage Scenarios:
Hospitals and Clinics: For diagnosing and monitoring acute phase responses, particularly in cases of infections and inflammation.
Emergency Departments: For rapid assessment of inflammatory responses in patients presenting with acute symptoms.
Diagnostic Laboratories: For routine testing of Serum Amyloid A (SAA) levels to differentiate between normal and minor acute phase responses, especially in mild infections.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc., where advanced diagnostic services are in demand for managing various acute and chronic conditions.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc., where healthcare systems are expanding and investing in modern diagnostic tools to enhance patient care.
Global Health Programs: International health initiatives focused on improving diagnostic capabilities and disease monitoring in low-resource settings.